Trial
NCT00254891
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
PF-3512676 + Paclitaxel + Carboplatin
Why stopped
See Termination Reason in Detailed Description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-30